A four-year-old Boston startup is getting $90 million to help develop radioactive molecules that target…
karnottDecember 11, 2023
Explore Now
News and Articles
Vital pulp therapy and root canal therapy (RCT) are the dominant treatment for irreversible pulpitis.…
karnottDecember 11, 2023
Adding an immunotherapy agent to the standard therapy for HER2+ metastatic breast cancer can significantly…
karnottDecember 11, 2023
Each gene in the human genome has two copies. When researchers detect two mutations within…
karnottDecember 8, 2023
Pancreatic cancer cells operate a recycling program that would be the envy of any municipality —…
pthomsonJanuary 4, 2023
Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including leukemias,…
pthomsonJanuary 4, 2023
People vary widely in how we think and behave and in our vulnerability to disease,…
pthomsonJanuary 3, 2023
During and after child birth, bacteria from the mother’s gut take up residence in the…
pthomsonJanuary 3, 2023
News and Articles
Amyotrophic Lateral Sclerosis (ALS), like many other neurodegenerative diseases, is highly heritable, but with only…
karnottMay 6, 2024
Bromodomain-containing protein 7 (BRD7) was initially identified as a tumor suppressor, but further research has…
karnottMay 6, 2024
Professor Gabriela Schlau-Cohen has been selected by the Protein Society as the winner of the…
karnottMay 3, 2024
Upcoming Events in Boston
Stay up-to-date with all of the life science events taking place in Boston with the Science in Boston events calendar!
